Prostate cancer progression correlates with increased humoral immune response to a human endogenous retrovirus GAG protein

Clinical Cancer Research

Volumn 19, Issue 22, 2013, Pages 6112-6125

  Reis, Bernardo Sgarbi ^a,g   Jungbluth, Achim A ^a   Frosina, Denise ^a   Holz, Megan ^a   Ritter, Erika ^a   Nakayama, Eiichi ^d   Ishida, Toshiaki ^d   Obata, Yuichi ^e   Carver, Brett ^b   Scher, Howard ^b   Scardino, Peter T ^b   Slovin, Susan ^b   Subudhi, Sumit K ^b   Reuter, Victor E ^b   Savage, Caroline ^b   Allison, James P ^a,h   Melamed, Jonathan ^c   Jäager, Elke ^f   Ritter, Gerd ^a,i   Old, Lloyd J ^a   Gnjatic, Sacha ^a,j   more..

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Surgery ^*  (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d OKAYAMA UNIVERSITY   (Japan)

^e RIKEN BIORESOURCE CENTER   (Japan)

^f KRANKENHAUS NORDWEST   (Germany)

^g ROCKEFELLER UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS   (United States)

ⁱ LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AUTOANTIBODY; GAG PROTEIN; PROTEIN ANTIBODY; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ANTIBODY DETECTION; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CHROMOSOME DELETION 22Q11; CONTROLLED STUDY; DEMETHYLATION; DISEASE ASSOCIATION; DISEASE COURSE; EARLY CANCER; ENDOGENOUS RETROVIRUS; GENETIC ASSOCIATION; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOGENICITY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN SYNTHESIS REGULATION; RECURRENCE RISK;

AGED; ANTIBODIES; AUTOANTIBODIES; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 22; DISEASE PROGRESSION; DNA METHYLATION; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, GAG; HELA CELLS; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; SURVIVAL; TUMOR MARKERS, BIOLOGICAL;

EID: 84888108951     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-3580     Document Type: Article

References (52)

1. Mayer J, Meese E. Human endogenous retroviruses in the primate lineage and their influence on host genomes. Cytogenet Genome Res 2005;110:448-56. (Pubitemid 41159921)
2. Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, Kirsch H, et al. HERV-K: the biologically most active human endogenous retrovirus family. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13 Suppl 1:S261-7.
3. Lavie L, Kitova M, Maldener E, Meese E, Mayer J. CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K (HML-2). J Virol 2005;79:876-83. (Pubitemid 40053871)
4. Schulz WA, Steinhoff C, Florl AR. Methylation of endogenous human retroelements in health and disease. Curr Top Microbiol Immunol 2006;310:211-50. (Pubitemid 47400292)
5. Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D, et al. Loss of epigenetic silencing in tumors preferentially affects primatespecific retroelements. Gene 2009;448:151-67.
6. Stengel S, Fiebig U, Kurth R, Denner J. Regulation of human endogenous retrovirus-K expression in melanomas by CpG methylation. Genes Chromosomes Cancer 2010;49:401-11.
7. Stoye JP, Moroni C, Coffin JM. Virological events leading to spontaneous AKR thymomas. J Virol 1991;65:1273-85.
8. Coffin JM, Stoye JP, Frankel WN. Genetics of endogenous murine leukemia viruses. Ann N Y Acad Sci 1989;567:39-49. (Pubitemid 19213349)
9. Obata Y, Stockert E, De Leo AB, O'Donnell PV, Snyder HW Jr, Old LJ. A cell surface antigen of the mouse related to xenotropic MuLv defined by naturally occurring antibody and monoclonal antibody. Relation to Gix G (rada1), G (aksl2) systems of MuLV-related antigens. J Exp Med 1981;154:659-75. (Pubitemid 11060779)
10. Stockert E, O'Donnell PV, Obata Y, Old LJ. Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus. Proc Natl Acad Sci U S A 1980;77:3720-4. (Pubitemid 10012930)
11. Stockert E, De Leo AB, O'Donnell PV, Obata Y, Old LJ. G (AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody. J Exp Med 1979;149:200-15. (Pubitemid 9081278)
12. De Leo AB, Shiku H, Takahashi T, John M, Old LJ. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma. J Exp Med 1977;146:720-34. (Pubitemid 8175981)
13. Chen YT. Cancer vaccine: identification of human tumor antigens by SEREX. Cancer J 2000;6 Suppl 3:S208-17.
14. Jager D. Potential target antigens for immunotherapy identified by serological expression cloning (SEREX). Methods Mol Biol 2007;360:319-26.
15. Ishida T, Obata Y, Ohara N, Matsushita H, Sato S, Uenaka A, et al. Identification of the HERV-K gag antigen in prostate cancer by SEREX using autologous patient serum and its immunogenicity. Cancer Immun 2008;8:15.
16. Hermans KG, van der Korput HA, van Marion R, van de Wijngaart DJ, Ziel-van der Made A, Dits NF, et al. Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer. Cancer Res 2008;68:7541-9.
17. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007;448:595-9. (Pubitemid 47206938)
18. Lee YN, Bieniasz PD. Reconstitution of an infectious human endogenous retrovirus. PLoS Pathog 2007;3:e10.
19. Herbst H, Sauter M, Mueller-Lantzsch N. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol 1996;149:1727-35. (Pubitemid 26363978)
20. Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997;71:4581-8. (Pubitemid 27204151)
21. Rakoff-Nahoum S, Kuebler PJ, Heymann JJ, E Sheehy M, Ortiz GM, S Ogg G, et al. Detection of T lymphocytes specific for human endogenous retrovirusK (HERV-K) in patientswithseminoma. AIDS ResHum Retroviruses 2006;22:52-6. (Pubitemid 43201518)
22. Schiavetti F, Thonnard J, Colau D, Boon T, Coulie PG. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res 2002;62:5510-6.
23. Hahn S, Ugurel S, Hanschmann KM, Strobel H, Tondera C, Schadendorf D, et al. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability. AIDS Res Hum Retroviruses 2008;24:717-23. (Pubitemid 351748779)
24. Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, et al. Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res 2008;68:5869-77.
25. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
26. Borley N, Feneley MR. Prostate cancer: diagnosis and staging. Asian J Androl 2009;11:74-80.
27. Ilic D, Green S. Prostate specific antigen for detecting early prostate cancer. BMJ 2009;339:b3572.
28. Stark JR, Mucci L, Rothman KJ, Adami HO. Screening for prostate cancer remains controversial. BMJ 2009;339:b3601.
29. Bensalah K, Lotan Y, Karam JA, Shariat SF. New circulating biomarkers for prostate cancer. Prostate Cancer Prostatic Dis 2008;11:112-20. (Pubitemid 351676597)
30. Steuber T, O'Brien MF, Lilja H. Serum markers for prostate cancer: a rational approach to the literature. Eur Urol 2008;54:31-40.
31. Lee MS, Igawa T, Chen SJ, Van Bemmel D, Lin JS, Lin FF, et al. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas. Int J Cancer 2004;108:672-8. (Pubitemid 38076398)
32. Gnjatic S, Old LJ, Chen YT. Autoantibodies against cancer antigens. Methods Mol Biol 2009;520:11-9.
33. Cheeseman IM, Desai A. A combined approach for the localization and tandem affinity purification of protein complexes from metazoans. Sci STKE 2005;2005:pl1.
34. Gnjatic S, Ritter E, Buchler MW, Giese NA, Brors B, Frei C, et al. Seromic profiling of ovarian and pancreatic cancer. Proc Natl Acad Sci U S A 2010;107:5088-93.
35. Cremer T, Kreth G, Koester H, Fink RH, Heintzmann R, Cremer M, et al. Chromosome territories, interchromatin domain compartment, and nuclear matrix: an integrated view of the functional nuclear architecture. Crit Rev Eukaryot Gene Expr 2000;10:179-212.
36. Gimenez J, Montgiraud C, Pichon JP, Bonnaud B, Arsac M, Ruel K, et al. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res 2010;38:2229-46.
37. Goering W, Ribarska T, Schulz WA. Selective changes of retroelement expression in human prostate cancer. Carcinogenesis 2011;32:1484-92.
38. Nakada T, Noguchi Y, Satoh S, Ono T, Saika T, Kurashige T, et al. NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer. Cancer Immun 2003;3:10.
39. Hoffmann TK, Trellakis S, Okulicz K, Schuler P, Greve J, Arnolds J, et al. Cyclin B1 expression and p53 status in squamous cell carcinomas of the head and neck. Anticancer Res 2011;31:3151-7.
40. Covini G, Chan EK, Nishioka M, Morshed SA, Reed SI, Tan EM. Immune response to cyclin B1 in hepatocellular carcinoma. Hepatology 1997;25:75-80. (Pubitemid 27014988)
41. Cools J, Wlodarska I, Somers R, Mentens N, Pedeutour F, Maes B, et al. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002;34:354-62. (Pubitemid 34787456)
42. Greif PA, Eck SH, Konstandin NP, Benet-Pages A, Ksienzyk B, Dufour A, et al. Identification of recurring tumor-specific somatic mutations in acute myeloid leukemia by transcriptome sequencing. Leukemia 2011;25:821-7.
43. Liu G, Huang YJ, Xiao R, Wang D, Acton TB, Montelione GT. Solution NMR structure of the ARID domain of human AT-rich interactive domain-containing protein 3A: a human cancer protein interaction network target. Proteins 2010;78:2170-5.
44. Stephenson AJ, Kattan MW, Eastham JA, Dotan ZA, Bianco FJ Jr, Lilja H, et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 2006;24:3973-8. (Pubitemid 46630746)
45. Sauter M, Schommer S, Kremmer E, Remberger K, Dolken G, Lemm I, et al. Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas. J Virol 1995;69:414-21. (Pubitemid 24378819)
46. Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, et al. Immunotherapeutic potential of anti-human endogenous retrovirus-k envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst 2012;104:189-210.
47. Lamont KR, Tindall DJ. Androgen regulation of gene expression. Adv Cancer Res 2010;107:137-62.
48. Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 2001;61:3550-5. (Pubitemid 32694958)
49. Ford OH 3rd, Gregory CW, Kim D, Smitherman AB, Mohler JL. Androgen receptor gene amplification and protein expression in recurrent prostate cancer. J Urol 2003;170:1817-21. (Pubitemid 37254935)
50. Florl AR, Steinhoff C, Muller M, Seifert HH, Hader C, Engers R, et al. Coordinate hypermethylation at specific genes in prostate carcinoma precedes LINE-1 hypomethylation. Br J Cancer 2004;91:985-94. (Pubitemid 39273795)
51. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 2008;68:8954-67.
52. Suyama T, Shiraishi T, Zeng Y, Yu W, Parekh N, Vessella RL, et al. Expression of cancer/testis antigens in prostate cancer is associated with disease progression. Prostate 2010;70:1778-87.